[go: up one dir, main page]

ES8403463A1 - "un procedimiento para la preparacion de un compuesto de imidazol". - Google Patents

"un procedimiento para la preparacion de un compuesto de imidazol".

Info

Publication number
ES8403463A1
ES8403463A1 ES515895A ES515895A ES8403463A1 ES 8403463 A1 ES8403463 A1 ES 8403463A1 ES 515895 A ES515895 A ES 515895A ES 515895 A ES515895 A ES 515895A ES 8403463 A1 ES8403463 A1 ES 8403463A1
Authority
ES
Spain
Prior art keywords
procedure
preparation
imidazole compound
already mentioned
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES515895A
Other languages
English (en)
Other versions
ES515895A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zambon SpA
Original Assignee
Zambon SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon SpA filed Critical Zambon SpA
Publication of ES8403463A1 publication Critical patent/ES8403463A1/es
Publication of ES515895A0 publication Critical patent/ES515895A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Epoxy Resins (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

CONSISTE EN HACER REACCIONAR UN PRODUCTO DE FORMULA (I), EN LA QUE R2, R3 Y R4 TIENEN EL SIGNIFICADO YA MENCIONADO, CON UN PRODUCTO DE FORMULA: R1-HO, EN LA QUE R1 TIENE EL SIGNIFICADO YA MENCIONADO.DE APLICACION EN MEDICINA POR SU ACTIVIDAD ANTITERAPEUTICA, ANALGESICA Y ANTIINFLAMATORIA.
ES515895A 1981-07-31 1982-07-30 "un procedimiento para la preparacion de un compuesto de imidazol". Granted ES515895A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT23270/81A IT1168008B (it) 1981-07-31 1981-07-31 Imidazol-eteri ed ester, procedimenti per prepararli e composizioni farmaceutiche che li contengono

Publications (2)

Publication Number Publication Date
ES8403463A1 true ES8403463A1 (es) 1984-04-01
ES515895A0 ES515895A0 (es) 1984-04-01

Family

ID=11205498

Family Applications (1)

Application Number Title Priority Date Filing Date
ES515895A Granted ES515895A0 (es) 1981-07-31 1982-07-30 "un procedimiento para la preparacion de un compuesto de imidazol".

Country Status (13)

Country Link
US (1) US4560696A (es)
EP (1) EP0074130B1 (es)
JP (1) JPS5849369A (es)
AT (1) ATE56707T1 (es)
AU (1) AU557494B2 (es)
CA (1) CA1186315A (es)
DE (1) DE3280245D1 (es)
DK (1) DK158944C (es)
ES (1) ES515895A0 (es)
GR (1) GR76886B (es)
IT (1) IT1168008B (es)
PT (1) PT75338B (es)
ZA (1) ZA825428B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206257A (en) * 1987-03-05 1993-04-27 May & Baker Limited Pesticidal method using 2-phenylimidazole derivatives
JP3612328B2 (ja) * 1992-07-20 2005-01-19 エーザイ株式会社 ベンゼン誘導体
US5616601A (en) * 1994-07-28 1997-04-01 Gd Searle & Co 1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation
US6613789B2 (en) 1994-07-28 2003-09-02 G. D. Searle & Co. Heterocyclo-substituted imidazoles for the treatment of inflammation
AR024222A1 (es) * 1998-10-16 2002-09-25 Palau Pharma Sa Imidazoles con actividad antiinflamatoria un procedimiento para su preparacion y composiciones farmaceuticas que lo contienen
AR032292A1 (es) 1999-12-16 2003-11-05 Schering Corp Imidazoles sustituidos, composiciones farmaceuticas y el uso de dichos imidazoles para la manufactura de un medicamento para los tratamientos de desordenes en la alimentacion
ES2159489B1 (es) * 2000-03-23 2002-04-16 Uriach & Cia Sa J Nuevos derivados de imidazol con actividad antiinflamatoria.
CN102775354A (zh) * 2011-05-10 2012-11-14 无锡立诺康医药科技有限公司 一种合成4-芳基-5-羧酸咪唑及其酯的工艺方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1570212A (en) * 1975-10-29 1980-06-25 Smithkline Corp Imidazoles
US4104473A (en) * 1976-04-23 1978-08-01 Shikoku Chemicals Corporation Novel imidazole compounds and process for preparations thereof
US4124766A (en) * 1977-02-03 1978-11-07 American Cyanamid Company Substituted 3-(4-imidazolylmethylene)carbazic and thiocarbazic acid esters
US4139708A (en) * 1977-05-24 1979-02-13 Sk&F Lab Co. Intermediates and processes useful for preparing medicinal agents imidazolemethylphosphonium salts
KR810000359B1 (ko) * 1980-03-31 1981-04-22 한국과학기술원 히드록시메틸이미다졸 화합물의 제조방법

Also Published As

Publication number Publication date
DK158944B (da) 1990-08-06
GR76886B (es) 1984-09-04
EP0074130B1 (en) 1990-09-19
IT8123270A0 (it) 1981-07-31
AU8660582A (en) 1983-02-03
IT1168008B (it) 1987-05-20
DE3280245D1 (de) 1990-10-25
PT75338B (en) 1985-01-04
JPH0337549B2 (es) 1991-06-05
DK341882A (da) 1983-02-01
IT8123270A1 (it) 1983-01-31
EP0074130A3 (en) 1983-08-10
ES515895A0 (es) 1984-04-01
CA1186315A (en) 1985-04-30
ATE56707T1 (de) 1990-10-15
AU557494B2 (en) 1986-12-24
US4560696A (en) 1985-12-24
EP0074130A2 (en) 1983-03-16
ZA825428B (en) 1983-08-31
PT75338A (en) 1982-08-01
JPS5849369A (ja) 1983-03-23
DK158944C (da) 1991-01-21

Similar Documents

Publication Publication Date Title
ES8407049A1 (es) Un procedimiento para la preparacion de compuestos biciclicos.
ES8504140A1 (es) Procedimiento para la preparacion de nuevos bencimidazoles substituidos
ES2061252T3 (es) Agente antitusivo y regulador de la mucosa, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
ATE61050T1 (de) Pyridazinamine wirksam gegen viren.
IT1256450B (it) Esteri nitrici con attivita' farmacologica e procedimento per la loro preparazione
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
ATE180773T1 (de) N-sulfonyl-2-oxoindol-derivate mit einer affinität für die vasopressin und/oder ocytocin rezeptoren
IT1190727B (it) Composto ad attivita' analgesica,antiinfiammatoria e mucoregolatrice procedimento per la sua preparazione e relative composizioni farmaceutiche
IS1564B (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
ES8403463A1 (es) "un procedimiento para la preparacion de un compuesto de imidazol".
ES8502688A1 (es) Procedimiento para preparar derivados de quinolina
ES2116612T3 (es) Nuevas bis-naftalimidas para el tratamiento del cancer.
ES8502703A1 (es) Un procedimiento para la preparacion de nuevos derivados de tienopirimidina.
ES2100396T3 (es) Derivados de 17-(3-furil)- y 17-(4-piridazinil)-5beta,14beta-androstano activos sobre el sistema cardiovascular, procesos para su preparacion y composiciones farmaceuticas que los contienen.
ES8402839A1 (es) Procedimiento para la obtencion de nuevos poliazaheterociclicos policiclicos.
IT8621874A0 (it) Procedimento di preparazione di additivi surbasati molto fluidi e a basicita' elevata, e composizione contenente i detti additivi.
ES8304952A1 (es) Procedimiento para preparar derivados de alcanolamina.
PT1001942E (pt) Poli-hidroxibutilpirazinas sua preparacao e medicamentos que as contem
FR2361387A1 (fr) Composition dermatologique
AU565470B2 (en) Triazolyl alcohols
DK401783D0 (da) Herbicidt aktive 2-aryl-2-azolylmethyl -1,3-dioxepiner
ATE28647T1 (de) Chinazolinonderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln.
SE8104675L (sv) Farmacevtisk komposition med antiflogistisk, antipyretisk och analgetisk verkan
IT8622783A0 (it) Derivati imidazolici adattivita' terapeutica, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
GB1527700A (en) 4(5)-rho-chlorophenyl-5(4)-methyl-imidazole and salts thereof

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19991102